Ferronova is a cancer diagnostics company, developing tracer systems for improved lymph node identification.
More than 40% of people will be diagnosed with cancer during their lifetime. Successful cancer treatment relies on accurate staging of how far, and where cancer has spread from a primary tumour. The lymphatic system is the primary pathway for the spread of most cancers.
Ferronova’s injectable magnetic and fluorescent tracers are able to less invasively, more quickly, and more accurately stage the spread of cancer resulting in: